CARLOS
MACAYA MIGUEL
Profesor emérito
Academic Medical Center
Ámsterdam, HolandaPublicaciones en colaboración con investigadores/as de Academic Medical Center (4)
2018
-
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
The Lancet, Vol. 392, Núm. 10151, pp. 940-949
2016
-
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
JACC: Cardiovascular Interventions, Vol. 9, Núm. 12, pp. 1231-1242
2008
-
Systemic exposure of everolimus after stent implantation: A pharmacokinetic study
American Heart Journal, Vol. 156, Núm. 4, pp. 751.e1-751.e7
2001
-
Continued benefit of coronary stenting versus balloon angioplasty: Five-year clinical follow-up of Benestent-I trial
Journal of the American College of Cardiology, Vol. 37, Núm. 6, pp. 1598-1603